MARKET

AMRX

AMRX

Amneal Pharmaceuticals Inc
NASDAQ
12.64
+0.31
+2.51%
After Hours: 12.88 +0.24 +1.90% 19:58 12/18 EST
OPEN
12.37
PREV CLOSE
12.33
HIGH
12.72
LOW
12.32
VOLUME
3.52M
TURNOVER
--
52 WEEK HIGH
12.72
52 WEEK LOW
6.69
MARKET CAP
3.97B
P/E (TTM)
766.06
1D
5D
1M
3M
1Y
5Y
1D
The Bull Case For Amneal Pharmaceuticals (AMRX) Could Change Following FDA Green Light For Hospital Epinephrine
Simply Wall St · 12h ago
Amneal: Growing Drug Portfolio, Positive Cash Flow, Outweighing Leverage Risks
Seeking Alpha · 1d ago
Weekly Report: what happened at AMRX last week (1208-1212)?
Weekly Report · 3d ago
The Bull Case For Amneal Pharmaceuticals (AMRX) Could Change Following Key FDA Wins For Epinephrine And Complex Generics
Simply Wall St · 12/10 22:17
Teva seeks removal of over 200 patents from FDA Orange Book after FTC challenge
Seeking Alpha · 12/10 17:56
Amneal Wins FDA Nod For Epinephrine Injection In Single-and Multi-Dose Vials
NASDAQ · 12/10 10:13
FDA Clears Amneal Epinephrine Injection
Dow Jones · 12/09 21:35
Amneal Pharmaceuticals announces FDA approval for epinephrine injection vials
TipRanks · 12/09 21:11
More
About AMRX
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Webull offers Amneal Pharmaceuticals Inc stock information, including NASDAQ: AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.